SCHEMBL13854148

SCHEMBL13854148

Fc1cc(F)cc(-c2cnc3[nH]ccc3c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 10/20 0.65
AXL P30530 2/20 0.65
PIK3CD O00329 1/20 0.63
PIK3CA P42336 1/20 0.63
PIK3CB P42338 1/20 0.63
PIK3CG P48736 1/20 0.63
RIPK1 Q13546 4/20 0.61
BRD4 O60885 1/20 0.57
PLK4 O00444 2/20 0.54
ROCK2 O75116 2/20 0.54
PRKD3 O94806 2/20 0.54
MAP4K4 O95819 2/20 0.54
INSR P06213 2/20 0.54
CDK1 P06493 2/20 0.54
ROS1 P08922 2/20 0.54
FER P16591 2/20 0.54
CDK2 P24941 2/20 0.54
MARK3 P27448 2/20 0.54
FLT4 P35916 2/20 0.54
KDR P35968 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4831501 0.87 CDK8 (0.81) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL3136284 0.87 CDK8 (0.71) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL413503 0.86 RIPK1 (0.71) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL297772 0.83 CDK8 (0.55) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL17854924 0.81 RIPK1 (0.64) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL13854147 0.80 RIPK1 (0.62) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL857265 0.80 RIPK1 (0.57) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL13854134 0.79 CDK8 (0.65) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL13854150 0.79 NUDT1 (0.56) CDK8AXLPIK3CDPIK3CAPIK3CB
SCHEMBL13854145 0.79 ALOX5AP (0.61) CDK8AXLPIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534800-B2 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders EISAI R & D DEVELOPMENT CO., LTD. (JP) 2009-05-19 US disclosed
US-7534800-B2 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders EISAI R & D DEVELOPMENT CO., LTD. (JP) 2009-05-19 US disclosed
US-7291630-B2 Azaindoles as inhibitors of c-Jun N-terminal kinases EISAI CO., LTD. (JP) 2007-11-06 US disclosed
US-7291630-B2 Azaindoles as inhibitors of c-Jun N-terminal kinases EISAI CO., LTD. (JP) 2007-11-06 US disclosed